Dialysis Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dialysis access program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dialysis Access Program Today - Breaking & Trending Today

Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Tonix Pharmaceuticals and Massachusetts General Hospital (MGH) Enter into Research .
Tonix Pharmaceuticals Holding Corp.January 5, 2021 GMT
Expands Ongoing Research Collaboration Between Tonix and MGH Studying TNX-1500 in Heart Transplantation
TNX-1500 May Hold Potential in Treating Autoimmune Diseases Including Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis
CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a second research collaboration agreement with Massachusetts General Hospital (MGH), a teaching hospital of Harvard Medical School, to develop TNX-1500, a humanized monoclonal antibody (mAb) that targets the CD40-ligand (also known as CD154, T-BAM or 5c8 antigen1) for the prevention and treatm ....

United States , Richardn Pierson , Jessica Morris , Tatsuo Kawai , Seth Lederman , Olipriya Das , Peter Vozzo , Tonix Pharmaceuticals , Harvard Medical School , Department Of Surgery , Exchange Commission , Ongoing Research Collaboration Between Tonix , Dialysis Access Program , Transplantation Sciences , Tonix Pharmaceuticals Holding Corp , Amgen Inc , Abbvie Inc , Professor Of Surgery At Harvard Medical School , Hold Potential , Rheumatoid Arthritis , Pharmaceuticals Holding , Massachusetts General Hospital , Surgical Director , Living Donor Transplantation , Ligand Antibody Engineering Led , Chief Executive Officer ,